CommentaryPublished 2016
Interferon-Related Secretome Plays a Vital Role in PD-L1 Expression in the Tumor Microenvironment after Direct Interaction between Immune Cells and Tumor Cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
PD-L1, also known as CD274 or B7-H1, is a major immune checkpoint protein . The binding of PD-L1 to its receptor PD-1 induces an inhibitory signal that suppresses the immune response by several mechanisms such as inhibiting the proliferation of CD8+ T effector cells. This research has resulted in the development of promising clinical drugs such as anti-PD-1 antibodies including Keytruda (pembrolizumab, Merck), and Opdivo (nivolumab, BMS) as well as the anti-PD-L1 antibody Tecentriq (atezolizumab, Roche), and other peptides and small molecule inhibitors for cancer immunotherapy. However, the mechanism by which tumor cells expressing PD-L1 regulate the function of infiltrating immune cells within the tumor microenvironment is still not well understood.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSingle Cell Biology
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Yuan-Qin Yang”
- BylineArticles whose byline prints “Jonathan Howard DeLong”
- BylineArticles whose byline prints “Kang-Jian Zhang”
